EYEPOINT PHARMACEUTICALS ($EYPT) posted quarterly earnings results for Q4 2025 on Wednesday, March 4th. The company reported earnings of -$0.81 per share, missing estimates of -$0.76 by $0.05. The company also reported revenue of $620,000, missing estimates of $1,030,200 by $-410,200.
You can see Quiver Quantitative's $EYPT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
EYEPOINT PHARMACEUTICALS Insider Trading Activity
EYEPOINT PHARMACEUTICALS insiders have traded $EYPT stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $EYPT stock by insiders over the last 6 months:
- ASSET MANAGEMENT, LP CORMORANT sold 60,000 shares for an estimated $942,240
- RAMIRO RIBEIRO (Chief Medical Officer) has made 0 purchases and 3 sales selling 47,703 shares for an estimated $795,476.
- NANCY LURKER has made 0 purchases and 3 sales selling 10,000 shares for an estimated $150,942.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
EYEPOINT PHARMACEUTICALS Hedge Fund Activity
We have seen 98 institutional investors add shares of EYEPOINT PHARMACEUTICALS stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC added 2,937,729 shares (+inf%) to their portfolio in Q4 2025, for an estimated $53,672,308
- CITADEL ADVISORS LLC removed 2,135,389 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $39,013,557
- BLACKROCK, INC. added 1,823,346 shares (+36.7%) to their portfolio in Q4 2025, for an estimated $33,312,531
- PARADIGM BIOCAPITAL ADVISORS LP added 1,686,110 shares (+84.1%) to their portfolio in Q4 2025, for an estimated $30,805,229
- SUVRETTA CAPITAL MANAGEMENT, LLC added 1,634,970 shares (+26.4%) to their portfolio in Q4 2025, for an estimated $29,870,901
- FEDERATED HERMES, INC. added 1,601,101 shares (+36.3%) to their portfolio in Q4 2025, for an estimated $29,252,115
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,240,218 shares (-18.2%) from their portfolio in Q3 2025, for an estimated $17,660,704
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
